title: A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients.
abstract: The American Academy of Pediatrics, evidence-based guidelines endorse the use of cephalosporin antibiotics for patients with reported allergies to penicillin, for the treatment of acute bacterial sinusitis and acute otitis media. Many physicians, however, remain reluctant to prescribe such agents. Although such concern is understandable, lack of consistent data regarding exactly what constitutes an initial penicillin-allergic reaction and subsequent cross-sensitivity to cephalosporins may be preventing many patients from receiving optimal antibiotic therapy. This article reviews evidence in support of the American Academy of Pediatrics recommendation. Included is an examination of the types and incidence of reactions to penicillins and cephalosporins; the frequency of cross-reactivity between these 2 groups of agents; experimental and clinical studies that suggest that side chain-specific antibodies predominate in the immune response to cephalosporins, thereby explaining the lack of cross-sensitivity between most cephalosporins and penicillins; the role of skin testing; and the risks of anaphylaxis. Specific recommendations for the treatment of patients on the basis of their responses to previously prescribed agents are summarized.
authors.affiliation: University of Rochester Medical Center, Elmwood Pediatric Group, 601 Elmwood Ave, Box 672, Rochester, NY 14642, USA. michael_pichichero@urmc.rochester.edu
authors.forename: Michael E
authors.initials: ME
authors.lastname: Pichichero
mesh_terms: D000707:Anaphylaxis / Q000139:chemically induced; D002511:Cephalosporins / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D003429:Cross Reactions; D004342:Drug Hypersensitivity / Q000276:immunology*; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D010033:Otitis Media / Q000188:drug therapy*; D010406:Penicillins / Q000009:adverse effects* / Q000276:immunology; D017410:Practice Guidelines as Topic; D012306:Risk; D012852:Sinusitis / Q000188:drug therapy*; D012882:Skin Tests; D012955:Societies, Medical; D014481:United States
chemical_list: D002511:Cephalosporins; D010406:Penicillins; D007073:Immunoglobulin E